I spent 3 days with pharma executives. They're suddenly taking longevity seriously.
Source: Business Insider ·
Inside the conference where FDA officials, Eli Lilly, Pfizer, and biotech leaders mapped out the future of longevity medicine.
From the source
Pharma executives, scientists, and founders agree: this is THE aging conference to attend.Hilary Brueck/BILongevity drugmakers gathered in Boston last weekend for their annual shindig.For the first time, the FDA showed up too.Longevity isn't a bad word in the pharma world anymore; it's an investment imperative.For decades, "longevity" was a word serious drug makers avoided. It conjured images of supplement gurus, Silicon Valley biohackers, and anti-aging hucksters — not legitimate medicines backed by clinical trials.That shifted last weekend.The 2026 Aging Research and Drug Discovery (ARDD) meeting — the most important longevity conference of the year — landed in the US. After more than a decade in Europe, it was held in Boston, the center of the US biotech industry.US regulators, executives from big pharma, and longevity upstarts came together for three days to discuss how drugs to combat age-related declines could become a reality, sooner rather than later. Executives from major…